Variant report
Variant | esv3348842 |
---|---|
Chromosome Location | chr11:119808427-119809271 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CTD-2523D13.1.1-5 | chr11:119808788-119808868 | NONHSAT024693 |
2 | lnc-CTD-2523D13.1.1-5 | chr11:119808789-119808868 | XLOC_009302 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs143294852 | chr11:119808481-119808482 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs573353936 | chr11:119808492-119808493 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs540667494 | chr11:119808511-119808512 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2006623 | chr11:119808535-119808536 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs114590838 | chr11:119808574-119808575 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183090513 | chr11:119808594-119808595 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs67639605 | chr11:119808622-119808623 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577335612 | chr11:119808628-119808629 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528526568 | chr11:119808629-119808630 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs530270564 | chr11:119808662-119808663 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs548370268 | chr11:119808666-119808667 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs114984051 | chr11:119808667-119808668 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1789793 | chr11:119808725-119808726 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs187630432 | chr11:119808739-119808740 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs192067298 | chr11:119808768-119808769 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs543002645 | chr11:119808783-119808784 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs56683142 | chr11:119808787-119808788 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs60280067 | chr11:119808789-119808790 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs536480574 | chr11:119808803-119808804 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs182349202 | chr11:119808855-119808856 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs10892499 | chr11:119808864-119808865 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs528523675 | chr11:119808865-119808866 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs534312927 | chr11:119808868-119808869 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs559042760 | chr11:119808952-119808953 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs116514840 | chr11:119808953-119808954 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs880004 | chr11:119808956-119808957 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs185869757 | chr11:119808967-119808968 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs375792355 | chr11:119809035-119809036 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs575053815 | chr11:119809048-119809049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs542051466 | chr11:119809109-119809110 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs200688191 | chr11:119809117-119809118 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188732211 | chr11:119809125-119809126 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs112285704 | chr11:119809127-119809128 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs202033139 | chr11:119809132-119809133 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs371651679 | chr11:119809139-119809140 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs373488643 | chr11:119809146-119809147 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs375731774 | chr11:119809147-119809148 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs199975151 | chr11:119809148-119809149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs201092536 | chr11:119809149-119809150 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs202171416 | chr11:119809150-119809151 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs368675745 | chr11:119809183-119809184 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs546298422 | chr11:119809190-119809191 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs11217587 | chr11:119809217-119809218 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Developmental delay | 21147756 | CNVD |
Emanuel syndrome | 21549014 | CNVD |
Emanuel syndrome | 18184694 | CNVD |
Non-syndromic sensorineural hearing loss | 18184694 | CNVD |
Acute lymphoblastic leukemia | 22581003 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Cancer | 21183584 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-syndromic sensorineural hearing loss | 16829213 | CNVD |
Non-syndromic sensorineural hearing loss | 16760666 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Neurocytoma | 17123091 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Breast cancer | 20409316 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Heart disease | 20551144 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Autism | 22543975 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 21509527 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 23813976 | CNVD |
Cancer | 17440070 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:119803000-119809000 | Enhancers | Fetal Muscle Leg | muscle |
2 | chr11:119805400-119809200 | Enhancers | Brain Hippocampus Middle | brain |
3 | chr11:119805600-119809000 | Enhancers | Brain Angular Gyrus | brain |
4 | chr11:119805600-119809800 | Enhancers | Brain Cingulate Gyrus | brain |
5 | chr11:119805800-119809000 | Enhancers | Brain Substantia Nigra | brain |
6 | chr11:119806600-119809400 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
7 | chr11:119807200-119809600 | Weak transcription | Fetal Heart | heart |
8 | chr11:119807400-119809200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr11:119807400-119812000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
10 | chr11:119807600-119808800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
11 | chr11:119808200-119808600 | Flanking Active TSS | Brain Inferior Temporal Lobe | brain |
12 | chr11:119808400-119808600 | Enhancers | H1 Cell Line | embryonic stem cell |
13 | chr11:119808400-119809800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
14 | chr11:119808600-119809000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
15 | chr11:119808600-119809000 | Enhancers | Brain Inferior Temporal Lobe | brain |
16 | chr11:119808600-119809400 | Weak transcription | H1 Cell Line | embryonic stem cell |
17 | chr11:119808800-119809600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
18 | chr11:119809000-119811600 | Weak transcription | Brain Inferior Temporal Lobe | brain |
19 | chr11:119809200-119809400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
20 | chr11:119809200-119809600 | Weak transcription | Brain Hippocampus Middle | brain |